Keyphrases
Schizophrenia
100%
Brain Samples
52%
Patients with Schizophrenia
37%
Gene Expression Analysis
36%
Meta-analysis
28%
Gene Expression
25%
Blood Samples
24%
Systematic Meta-analysis
23%
Brodmann Area 10
14%
Down Syndrome
13%
Transcription Factor
12%
Leukemia
12%
Hypoxia-inducible factor-1α (HIF-1α)
12%
Healthy Controls
11%
Gene Expression Data
11%
Chromosome 21
11%
Expression Data
10%
Fear of COVID-19
10%
Differential Expression
10%
Acute Lymphoblastic Leukemia
10%
Superior Temporal Gyrus
9%
Proteasome Subunits
9%
FKBP5
9%
Sex Chromosome Aneuploidy
8%
Putative Binding Site
8%
Transcription Factor Binding Sites
8%
Biological Mechanisms
8%
Trisomy 21
7%
Severe Mental Illness
7%
Gene Downregulation
7%
MicroRNA
7%
Encoding Gene
7%
Cerebellum
7%
Inpatient Psychiatric Care
6%
Buffering Effect
6%
Inhibitory Signaling
6%
Sample Support
6%
CREB-binding Protein
6%
Treatment-resistant Depression
6%
Transcriptional Response
6%
Seminatural Environment
6%
Manual Tracking
6%
Janus Kinase 2 (JAK2)
6%
Automatic Phenotyping
6%
Mitochondrial Ribosome
6%
Heterogeneous Disease
6%
Cytokine Receptor-like Factor 2
6%
Aberrant Expression
6%
Response to Treatment
6%
Comprehensive Gene Expression Analysis
6%
Neuroscience
Meta-Analysis
75%
Gene Expression
71%
Ribosome
17%
Brodmann Area 10
15%
Proteasome
14%
Promoter Region
13%
Expression Analysis
10%
Superior Temporal Gyrus
10%
Binding Site
9%
MicroRNA
9%
Transcription Factors
9%
GABA Receptor
8%
Cerebellum
8%
Transcriptome
7%
Genome-Wide Association Study
6%
Treatment-Resistant Depression
6%
Cognitive Behavioral Therapy
6%
P53
6%
Multigene Family
6%
Social Behavior
6%
ATP Synthase
6%
microRNA 125b
6%
ETV6
6%
Electroconvulsive Therapy
6%
Receptor Subunit
6%
RUNX1
6%
Calcium Signaling
6%
Voltage-Dependent Anion Channel
6%
Psychiatry
6%
Cyclic AMP Responsive Element Binding Protein
6%
Activating Transcription Factor 2
6%
Cyclic AMP Responsive Element Binding Protein Binding Protein
6%
Receptor Gene
6%
Cannabinoid 1 Receptor
6%
Cannabinoid Receptor
6%
Signal Transduction
6%
Astrocyte
6%
Drug Therapy
6%
